CN111617202A - 一种降尿酸茶 - Google Patents

一种降尿酸茶 Download PDF

Info

Publication number
CN111617202A
CN111617202A CN202010394791.6A CN202010394791A CN111617202A CN 111617202 A CN111617202 A CN 111617202A CN 202010394791 A CN202010394791 A CN 202010394791A CN 111617202 A CN111617202 A CN 111617202A
Authority
CN
China
Prior art keywords
parts
uric acid
tea
group
gout
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010394791.6A
Other languages
English (en)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Bituo Human Resources Co ltd
Original Assignee
Guangzhou Bituo Human Resources Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Bituo Human Resources Co ltd filed Critical Guangzhou Bituo Human Resources Co ltd
Priority to CN202010394791.6A priority Critical patent/CN111617202A/zh
Publication of CN111617202A publication Critical patent/CN111617202A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967Lilium, e.g. tiger lily or Easter lily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

一种降尿酸茶,由下列组合物组成,各组合物重量(g)为:葛根20、枸杞15、百合10、山楂10、金银花25、桑葚子15、苦苣15、决明子15、薏米仁15、竹叶15、马齿苋15。本茶是以药食同源植物为原料,经现代化提取喷干而制成的代用茶剂,完全符合国家食品及代用茶标准,无任何化学品添加,长期服用对人体无任何不良影响,本代用茶可迅速减轻痛苦与痛风症状。

Description

一种降尿酸茶
技术领域
本发明涉及药食同源的中药应用领域,具体涉及一种降尿酸茶及其制备方法。
背景技术
痛风又称“高尿酸血症”,痛风是一种单钠尿酸盐(MSU)沉积所致的晶体相关性关节病,与嘌呤代谢紊乱及(或)尿酸排泄减少所致的高尿酸血症直接相关,属代谢性风湿病范畴。痛风可并发肾脏病变,严重者可出现关节破坏、肾功能损害,常伴发高脂血症、高血压病、糖尿病、动脉硬化及冠心病等。
现有治疗痛风的西医用药副作用较大,本发明提供了一种降尿酸的茶,降低尿酸速度快,预防及治疗痛风效果好。无任何毒副作用。
发明内容
本发明提供了一种降尿酸的茶,降低尿酸速度快,预防及治疗痛风效果好。无任何毒副作用。本茶是以药食同源植物为原料,经现代化提取喷干而制成的代用茶剂,完全符合国家食品及代用茶标准,无任何化学品添加,长期服用对人体无任何不良影响,本代用茶可迅速减轻痛苦与痛风症状。
本发明采用的技术方案如下:
本发明为一种可以降尿酸的茶,由下列组分组成,各组分的重量份为:葛根20、枸杞15、百合10、山楂10、金银花25、桑葚子15、苦苣15、决明子15、薏米仁15、竹叶15马齿苋15。
实验报告
实验动物:昆明雌性小鼠
动物来源:南方医科大学动物实验中心
分组:60只,最终分组为6组空白对照组、模型对照组、阳性药物对照组,低剂量组、中剂量组、高剂量组共组,每组10只,共60只
造模方法:
釆用升高尿酸药物(600mg/kg黄瞟吟+250mg/kg盐酸乙胺丁醇片),灌胃给药,给药体积为20ml/kg(最大给药体积)。
空白对照组:仅给予生理盐水,不做造模处理
模型对照组:给与上述升血尿酸药物灌胃5天进行造模
阳性药物对照组:给予上述升高血尿酸药物5天进行造模,期间并给予非布索坦60mg/kg进行治疗,连续药2周
低剂量组:给予上述升高血尿酸药物5天进行造模,期间并给予非布索坦5mg/kg进行治疗,连续药2周
中剂量组:给予上述升高血尿酸药物5天进行造模,期间并给予非布索坦8mg/kg进行治疗,连续药2周
高剂量组:给予上述升高血尿酸药物5天进行造模,期间并给予非布索坦12.80mg/kg进行治疗,连续药2周
血液采集和指标检测
松测标本的采集;很后一次给药后2小时,小鼠眼眶取血,室温放置1H,3500r/min低温离心10min,取血液放置冻存管内,-80℃超低温冰箱保存待测血清尿酸(UA),按试剂盒说明书操作步骤进行。
数据统计:
所有统计学分析均采用SPSS13.0统计学软件进行分析,计量發料符合正态分布的用均数±标准差(x±S)表示,不符合正态分布的计量资料应用中位数(四分位数间距)表示,组间差异用one way-ANOVA进行统计检验,P<0.05认为具有统计学意义
血尿酸结果
各组小鼠与实验结束后取材进行血尿酸检验,发现与模型组相比较,阳性对照组具有极显著差异(P<0.01),模型组与空白组相比,具有显著差异(p<0.05),说明实验系统稳定可靠,给药组中,高剂量组、中剂量组与低剂量组与模型组相比较,尿酸显著降低(P<0.05),各剂置组之间的呈现剂量相关性。数据见表1
表1:各组小鼠血尿酸结果(Mean±SD)
组别 N 血清尿酸(umol/L)
模型对照组 10 159.5±68.8Δ
空白对照组 10 60.7±33.1
阳性对照组(非布索坦) 10 54.6±18.5**
低剂量组 10 83.6±31.6*
中剂量组 10 60.8±27.6**
高剂量组 10 47.4±23.8**
注:与模型组相比,**p<0.01,*p<0.05,与空白组相比,Δp<0.05
黄喋吟氧化酶(XOD)结果
各组小鼠血液进行OXD活性检测,与空白组相比较,模型组和低剂量组OXD活性明显增高,具有显著差异(P<0.05),OXD活性增强,具有显著性差异(P<0.05),而中剂量组、与高剂暈组和阳性药物组则未见差异(P>0.05)与模型组相比较,高剂量组与阳性药物组OXD活性明显偏低,具有显著差异(P<0.05),数据见表2
表2各组小鼠皿XOD结果(Mean土SD)
组别 N 血清XOD(mmol/L)
模型对照组 10 0.61±0.11Δ
空白对照组 10 0.30±0.06*
阳性对照组(非布索坦) 10 0.24±0.05**
低剂量组 10 0.35±0.09*
中剂量组 10 0.33±0.10**
高剂量组 10 0.21±0.07**
注:与模型组相比,*p<0.05,与空白组相比,Δp<0.05
结论
在实验条件下,受试物的降尿酸作用与阳性药物非布索坦类似,两者无统计显著性差异,各剂量之间具有剂量相关性,表明受试物具有良好的降尿酸作用!
备注:关于非布索坦(西药)
非布索坦:英文名:Febuxostat,商品名:ULORIC(TAKEDA公司),类别:抗痛风药,适应症:用于治疗痛风的慢性高尿酸血证。剂型:片剂,规格:80mg、120mg非布索坦属片剂,是抗痛风药。非布索坦对氧化型和还原型的XOR均有显著的抑制作用,可用于治疗痛风的慢性高尿酸血症。不良反应包括肝功能异常、腹泻、头痛、关节相关征和症状及肌骨骼/结缔组织症状。
制备方法:
痛风茶配制工艺:将上述各种原料熬制并喷干成粉后,按比例加入三维混合机充分混合。混合后的茶粉加入一步沸腾制粒机,制粒完成后即可进行定量分装。
每袋4-7g,每天早晚各一袋,开水泡茶饮用。
具体实施方式
一种降尿酸茶,由下列组分组成,各组分的重量(g)为:葛根20、枸杞15、百合10、山楂10、金银花25、桑葚子15、苦苣15、决明子15、薏米仁15、竹叶15马齿苋15。
将上述各种原料熬制并喷干成粉后,按比例加入三维混合机充分混合。混合后的茶粉加入一步沸腾制粒机,制粒完成后即可进行定量分装。每袋7g。
服用方法:每袋7克,早晚各服一袋,温开水冲服。
性状:咖啡色,微苦,一冲即化。
禁忌:无任何禁忌,适用各类痛风人群及高尿酸患者,安全无任何毒副作用,痛风茶完全是用十余种药食同源的植物提取物配制而成。一种预防及消除痛风症状(红、肿、热、痛)有效降低尿酸的代用茶,完全由药食同源植物制成,没有任何添加,不含化学成分与抗生素,久服对人体无损害,长期使用辅助治疗效果好,无副作用,无依赖性!
典型病例
病例1.
程某,男,51岁,1年来间断出现双侧足拇趾关节反复红肿。症见右侧足拇趾关节红肿,压痛明显,大便秘结。舌红,苔黄厚腻,脉滑数。查血尿酸值:539umol/L。患者平素嗜食肥厚,在当地医院诊断为痛风。饮用本茶3天后,疼痛消失。
病例2.
苏某,男,63岁,嗜酒,患有高血压病,心脏病且做过心脏搭桥手术,5年前出现右足拇趾关节红肿。在当地医院查血尿酸高,诊断为痛风。本人考虑到西药药物的副作用较大,不愿意吃西药。嘱其继续饮用降尿酸茶,饮用本茶7天后,疼痛消失.经查尿酸值正常。

Claims (5)

1.一种降尿酸茶,由下列组合物组成,各组合物重量(g)为:葛根20、枸杞15、百合10、山楂10、金银花25、桑葚子15、苦苣15、决明子15、薏米仁15、竹叶15、马齿苋15。
2.按照权利要求1所述的药物组合物,各组合物重量(g)范围为:葛根17-23、枸杞12-18、百合7-13、山楂7-13、金银花22-28、桑葚子12-18、苦苣12-18、决明子12-18、薏米仁12-18、竹叶12-18、马齿苋12-18。
3.按照权利要求1、2所述的任意一项组合物,其特征是:可按常规的中药制剂方法制备成任何一种常用的口服制剂。
4.按照权利要求3所述的组合物,其特征是:所述的食品或口服制剂:丸剂、胶囊剂、片剂、散剂或颗粒剂等制剂。
5.权利要求1~4所述的任一组合物在制备预防痛风与降低尿酸的应用。
CN202010394791.6A 2020-05-09 2020-05-09 一种降尿酸茶 Pending CN111617202A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010394791.6A CN111617202A (zh) 2020-05-09 2020-05-09 一种降尿酸茶

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010394791.6A CN111617202A (zh) 2020-05-09 2020-05-09 一种降尿酸茶

Publications (1)

Publication Number Publication Date
CN111617202A true CN111617202A (zh) 2020-09-04

Family

ID=72255105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010394791.6A Pending CN111617202A (zh) 2020-05-09 2020-05-09 一种降尿酸茶

Country Status (1)

Country Link
CN (1) CN111617202A (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103931846A (zh) * 2014-04-25 2014-07-23 杨剑礼 一种降尿酸保健茶
CN109316566A (zh) * 2018-11-30 2019-02-12 湖北仙芝堂生物科技有限公司 一种可以降尿酸代用茶的生产方法
CN109674958A (zh) * 2018-12-21 2019-04-26 雷允上药业集团有限公司 一种具有降尿酸功效的中药组合物及其制备方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103931846A (zh) * 2014-04-25 2014-07-23 杨剑礼 一种降尿酸保健茶
CN109316566A (zh) * 2018-11-30 2019-02-12 湖北仙芝堂生物科技有限公司 一种可以降尿酸代用茶的生产方法
CN109674958A (zh) * 2018-12-21 2019-04-26 雷允上药业集团有限公司 一种具有降尿酸功效的中药组合物及其制备方法和应用

Similar Documents

Publication Publication Date Title
CN109674958B (zh) 一种具有降尿酸功效的中药组合物及其制备方法和应用
CN102370687B (zh) 一种治疗结肠炎的中药复方制剂及其制备方法
CN105078956A (zh) 连翘苷元在制备预防或治疗肝损伤或肝衰竭药物中的应用
CN112168876A (zh) 一种具有降血脂作用的组合物及其制备方法和应用
CN104958381A (zh) 一种治疗痛风的中药组合物
CN110960624A (zh) 一种抗疲劳的组合物及其制备方法
CN108815218B (zh) 药物组合物及其用途
CN111617202A (zh) 一种降尿酸茶
CN106109564A (zh) 治疗脑血栓的药物组合物及其制备方法
CN103655651B (zh) 一种灯台叶浸膏和提取物及其制备方法
CN114588141A (zh) 一种用于治疗银屑病的药物
CN113648302A (zh) 用于治疗前列腺炎或前列腺增生的药物
KR101911877B1 (ko) 생약재 추출물을 유효성분으로 포함하는 관절염 개선용 건강기능식품 조성물
CN105194658A (zh) 一种治疗肥胖增强体质的中药制剂及其制备方法
CN103830435A (zh) 一种治疗痛风的中药组合物
CN107496485A (zh) 毛大丁草的益肝作用及应用技术
CN103055094B (zh) 治疗白血病的中药及其制备方法
AU2021106230A4 (en) Medicinal diet composition for preventing and treating hyperuricemia and gout and preparation method thereof
CN108926525A (zh) 一种关节炎外用透皮吸收制剂
CN117582450B (zh) 一种防治动脉硬化、冠心病及痛风的药物组合物及制剂
CN103893512B (zh) 一种治疗痛风性关节炎的中药组合物
CN110448622B (zh) 治疗热性感冒的药物及其制备方法和应用
CN107213323B (zh) 一种滋阴化痰、散结解毒的中药复方制剂及其用途
CN107669971A (zh) 六味木香制剂在制备预防治疗风湿及并发症的药物中的应用
CN108066397A (zh) 药物组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Cheng Xiangyang

Document name: Notification of Entering the Substantive Examination Phase of an Invention Patent Application

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Cheng Xiangyang

Document name: Notice of Approval for Fee Reduction

DD01 Delivery of document by public notice